Showing results (41-50 of 326) with videos related to
Sort By:
Pageof 33
Clinical Neuropharmacology|October 1, 1992
Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathiesM C DalakasAnnals of Internal Medicine|May 1, 1997
Intravenous immune globulin therapy for neurologic diseasesM C DalakasJournal of the Neurological Sciences|January 8, 1999
Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15N Sambuughin, K Sivakumar, B Selenge, et al.Annals of Neurology|August 1, 1995
Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathyK Sivakumar, L Cervenáková, M C Dalakas, et al.Annals of Neurology|June 1, 1995
Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cellsM C Dalakas, I IllaThe American Journal of Pathology|August 6, 1999
Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathiesK Murata, M C DalakasNeurology|April 13, 2000
The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositisM Li, M C DalakasJournal of Neuroimmunology|May 18, 2000
Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathiesM Li, M C DalakasPageof 33